Kirk Malloy

Kirk Malloy has over 25 years of experience in the life sciences and healthcare industries. Kirk is currently a member of the Board of Directors at Jumpcode Genomics. Kirk has also served on the Board of Directors for Tagomics, Phoseon Technology, Verogen, NanoString Technologies, Inc., and JumpCode Genomics. In addition, they were a founding member and Chairman of the Board of Directors for BioAdvisors, LLC. From April 2016 to June 2021, they were a member of the Board of Directors for igenomx, and from March 2016 to May 2018, they were a member of the Board of Directors for Edico Genome. Kirk also served as Chairman of the Board of Directors for Organovo, Inc. from December 2014 to September 2020.

Kirk Malloy has a B.S. in Marine Science/Biology from the University of Miami, an M.S. and Ph.D. in Marine Biology/Biochemistry from the University of Delaware, and is certified as a Corporate Director from UCLA Anderson School of Management. Kirk also attended Seneca Valley High School.